Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of PSN821 in Type 2 Diabetes
NCT01386099Phase 2Completed
- Sponsor
- Prosidion Ltd.
- Start
- May 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PSN821 in type 2 diabetes mellitus (T2DM), sponsored by Prosidion Ltd.. Started May 2011; status: completed.
02
Drugs
PSN821
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01386099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01386099.